MAGFORCEMulti-Agency Gang Task Force
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
At a 2015 biotechnology conference, where he ( praised MagForce cancer technology as a potentially life-saving treatment, he said FDA regulations "kill a lot of people" by delaying the approval of drugs to the market.
MagForce AG, listed in the entry standard of the Frankfurt Stock Exchange (MF6, ISIN: DE000A0HGQF5), together with its subsidiary MagForce USA, Inc.
MagForce, the only group to have tested nanomagnet therapy in people, appears closest to commercialization.
According to MagForce, the IDE submission follows the submission of our pre-IDE submission to FDA in November, 2014 and a subsequent in-person meeting with FDA in January, 2015.
The Center for Integrated Oncology at Cologne University Hospital has initiated therapy using German medical device company MagForce AG's (XETRA: MF6) NanoTherm in a commercial setting for the treatment of brain cancers in addition to proceeding with an ongoing post-marketing study of the device, the company said on Thursday.
German medical device maker MagForce AG has installed the fifth NanoActivator for the treatment of brain tumors, the company said on Monday.
M2 PHARMA-March 27, 2015-Kiel University Hospital Starts Brain Cancer Treatment Using MagForce's NanoTherm
German medical device company MagForce AG has installed the fourth NanoActivator device at Cologne University Hospital, the company said on Monday.
MagForce AG (Frankfurt, XETRA: MF6), a medical device company in the field of nanomedicine with a focus on oncology, has signed a distribution agreement with Tek Grup Inc, a Turkish medical product distribution company.
Medical technology company MagForce AG (Frankfurt:MF6) on Wednesday announced it has completed a share placement with institutional investors.
14 December 2011 - MagForce Nanotechnologies AG (ETR:MF6), a Germany-based company specialising in the provision of nanotechnology solutions for the treatment of cancer, said on Wednesday it had signed a preliminary distribution agreement for its NanoTherm therapy in Russia and Kazakhstan with Delrus Inc, a Russian medical products wholesaler.